• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性咳嗽患者诊断和治疗程序使用及效果的医生认知调查

A Survey of Physicians' Perception of the Use and Effectiveness of Diagnostic and Therapeutic Procedures in Chronic Cough Patients.

机构信息

Pulmonology Department, University Hospital Gregorio Marañón, Madrid, Spain.

Servicio de Neumología. Hospital Universitario Gregorio Marañón, c/ Dr. Esquerdo 46, 28007, Madrid, Spain.

出版信息

Lung. 2021 Oct;199(5):507-515. doi: 10.1007/s00408-021-00475-1. Epub 2021 Sep 17.

DOI:10.1007/s00408-021-00475-1
PMID:34533587
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8510925/
Abstract

PURPOSE

The aim of this study was to understand the perception of family physicians, pulmonologists, and allergists with respect to diagnostic tests performed on patients with chronic cough and treatments prescribed to patients with refractory or unexplained chronic cough. We also assessed how these health professionals perceived the effectiveness of these treatments.

METHODS

An anonymous survey was distributed by the scientific societies SEPAR, SEAIC, SEMERGEN, semFYC, and SEMG. Respondents were asked how often they perform diagnostic tests and prescribe treatments (responses from 1 = never to 10 = always) and how they perceived the effectiveness of the drugs used (from 1 = not at all to 10 = very effective). The correlation between perceived effectiveness and frequency of prescription was analyzed.

RESULTS

The respondents comprised 620 family physicians, 92 pulmonologists, and 62 allergists. The most frequently performed diagnostic tests were chest x-ray and, among pulmonologists and allergists, simple spirometry and bronchodilator tests. The most frequently prescribed drugs were bronchodilators (percentages scoring 8-10 for each specialty: 43.2%, 42.4%, and 56.5%; p = 0.127), inhaled corticosteroids (36.9%, 55.4%, and 54.8%; p < 0.001), and antitussives (family physicians, 33.4%). Regarding perceived effectiveness, only bronchodilators, inhaled or oral corticosteroids, and opioids obtained a median effectiveness score > 5 (between 6 and 7). Correlation coefficients (ρ) suggested that approximately 45% of prescription was related to perceived effectiveness.

CONCLUSION

Although chronic cough is a common problem, diagnosis and treatment differ among specialists. The perceived effectiveness of drugs is generally low.

摘要

目的

本研究旨在了解家庭医生、肺科医生和过敏科医生对慢性咳嗽患者进行诊断测试以及对难治性或不明原因慢性咳嗽患者进行治疗的看法。我们还评估了这些卫生专业人员如何看待这些治疗方法的有效性。

方法

通过 SEPAR、SEAIC、SEMERGEN、semFYC 和 SEMG 科学协会分发了一份匿名调查。受访者被要求回答他们进行诊断测试和开处方治疗的频率(从 1=从不到 10=总是),以及他们如何看待所用药物的有效性(从 1=根本没有到 10=非常有效)。分析了感知效果与处方频率之间的相关性。

结果

受访者包括 620 名家庭医生、92 名肺科医生和 62 名过敏科医生。最常进行的诊断测试是胸部 X 光检查,而在肺科医生和过敏科医生中,最常进行的是简单肺量测定和支气管扩张剂测试。最常开的药物是支气管扩张剂(每个专科评分 8-10 的百分比:43.2%、42.4%和 56.5%;p=0.127)、吸入皮质类固醇(36.9%、55.4%和 54.8%;p<0.001)和镇咳药(家庭医生为 33.4%)。关于感知效果,只有支气管扩张剂、吸入或口服皮质类固醇和阿片类药物的中位效果评分>5(6-7 分之间)。相关系数(ρ)表明,大约 45%的处方与感知效果有关。

结论

尽管慢性咳嗽是一个常见问题,但不同专家的诊断和治疗方法存在差异。药物的感知效果普遍较低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f60b/8510925/cad5529cb5ad/408_2021_475_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f60b/8510925/cad5529cb5ad/408_2021_475_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f60b/8510925/cad5529cb5ad/408_2021_475_Fig1_HTML.jpg

相似文献

1
A Survey of Physicians' Perception of the Use and Effectiveness of Diagnostic and Therapeutic Procedures in Chronic Cough Patients.慢性咳嗽患者诊断和治疗程序使用及效果的医生认知调查
Lung. 2021 Oct;199(5):507-515. doi: 10.1007/s00408-021-00475-1. Epub 2021 Sep 17.
2
[Perceptions of family doctors, pulmonologists and allergists on the approach to patients with chronic cough. Results of an anonymous survey].[家庭医生、肺科医生和过敏症专科医生对慢性咳嗽患者诊疗方法的看法。一项匿名调查结果]
Semergen. 2021 Sep;47(6):376-384. doi: 10.1016/j.semerg.2021.04.005. Epub 2021 Jun 8.
3
Use of National Asthma Guidelines by Allergists and Pulmonologists: A National Survey.过敏症专科医生和肺科医生对国家哮喘指南的使用情况:一项全国性调查。
J Allergy Clin Immunol Pract. 2020 Oct;8(9):3011-3020.e2. doi: 10.1016/j.jaip.2020.04.026. Epub 2020 Apr 25.
4
Canadian Health Care Professionals' Familiarity with Chronic Cough Guidelines and Experiences with Diagnosis and Management: A Cross-Sectional Survey.加拿大医疗保健专业人员对慢性咳嗽指南的熟悉程度以及诊断和管理经验:一项横断面调查。
Lung. 2023 Feb;201(1):47-55. doi: 10.1007/s00408-023-00604-y. Epub 2023 Feb 18.
5
Asthma care practices, perceptions, and beliefs of Chicago-area asthma specialists. Chicago Asthma Surveillance Initiative Project Team.芝加哥地区哮喘专家的哮喘护理实践、认知与信念。芝加哥哮喘监测倡议项目团队。
Chest. 1999 Oct;116(4 Suppl 1):154S-162S. doi: 10.1378/chest.116.suppl_2.154s.
6
Understanding physician's knowledge and perception of chronic cough in Switzerland.了解瑞士医生对慢性咳嗽的认识和看法。
Curr Med Res Opin. 2022 Aug;38(8):1459-1466. doi: 10.1080/03007995.2022.2057154. Epub 2022 Apr 15.
7
A Belgian survey on the diagnosis of asthma-COPD overlap syndrome.一项关于哮喘-慢性阻塞性肺疾病重叠综合征诊断的比利时调查。
Int J Chron Obstruct Pulmon Dis. 2017 Feb 13;12:601-613. doi: 10.2147/COPD.S124459. eCollection 2017.
8
Thai pediatricians' current practice toward childhood asthma.泰国儿科医生对儿童哮喘的当前诊疗实践。
J Asthma. 2018 Apr;55(4):402-415. doi: 10.1080/02770903.2017.1338724. Epub 2017 Jul 11.
9
Electronic cigarettes: How confident and effective are allergists, pulmonologists, and primary care physicians in their practice behavior?电子烟:过敏症专家、肺病专家和初级保健医生在实践行为中的信心和有效性如何?
Allergy Asthma Proc. 2020 May 1;41(3):192-197. doi: 10.2500/aap.2020.41.200009.
10
Diagnosis and management of asthma, COPD and asthma-COPD overlap among primary care physicians and respiratory/allergy specialists: A global survey.基层医疗医生与呼吸科/过敏科专家对哮喘、慢性阻塞性肺疾病及哮喘-慢性阻塞性肺疾病重叠综合征的诊断与管理:一项全球调查。
Clin Respir J. 2019 Jun;13(6):355-367. doi: 10.1111/crj.13016. Epub 2019 Mar 24.

引用本文的文献

1
Etiologies and Treatment Outcomes of Chronic Cough Diagnosed with a Pathophysiological Diagnostic Procedure: A Single-center Retrospective Observational Cohort Study.采用病理生理诊断方法诊断的慢性咳嗽的病因及治疗结果:一项单中心回顾性观察队列研究
Thorac Res Pract. 2025 Apr 30;26(3):97-106. doi: 10.4274/ThoracResPract.2024.24049. Epub 2025 Jan 27.
2
Patient satisfaction with the management of refractory and unexplained chronic cough in Canada: Results from a national survey.加拿大患者对难治性和不明原因慢性咳嗽管理的满意度:一项全国性调查的结果。
PLoS One. 2024 Aug 1;19(8):e0308275. doi: 10.1371/journal.pone.0308275. eCollection 2024.
3

本文引用的文献

1
Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial.Gefapixant,一种 P2X3 受体拮抗剂,用于治疗难治性或原因不明的慢性咳嗽:一项随机、双盲、对照、平行分组、2b 期试验。
Lancet Respir Med. 2020 Aug;8(8):775-785. doi: 10.1016/S2213-2600(19)30471-0. Epub 2020 Feb 25.
2
ERS guidelines on the diagnosis and treatment of chronic cough in adults and children.ERS 指南:成人和儿童慢性咳嗽的诊断与治疗。
Eur Respir J. 2020 Jan 2;55(1). doi: 10.1183/13993003.01136-2019. Print 2020 Jan.
3
Exhaled nitric oxide in chronic cough: A good tool in a multi-step approach.
A survey of UK respiratory specialists' opinion on the management of chronic cough.
英国呼吸科专家对慢性咳嗽管理的意见调查。
ERJ Open Res. 2024 Jul 29;10(4). doi: 10.1183/23120541.00021-2024. eCollection 2024 Jul.
4
Characteristics, demographics, and epidemiology of possible chronic cough in Sweden: A nationwide register-based cohort study.瑞典可能慢性咳嗽的特征、人口统计学和流行病学:一项基于全国登记的队列研究。
PLoS One. 2024 Jul 24;19(7):e0303804. doi: 10.1371/journal.pone.0303804. eCollection 2024.
5
Epidemiology and Healthcare Service Utilization among Adults with Chronic Cough.慢性咳嗽成年人的流行病学及医疗服务利用情况
J Clin Med. 2024 May 30;13(11):3230. doi: 10.3390/jcm13113230.
6
Knowledge, attitude, and practice of healthcare providers on chronic refractory cough: A cross-sectional study.医疗服务提供者对慢性难治性咳嗽的知识、态度和实践:一项横断面研究。
Heliyon. 2024 Mar 5;10(6):e27564. doi: 10.1016/j.heliyon.2024.e27564. eCollection 2024 Mar 30.
7
Patient-reported experiences with refractory or unexplained chronic cough: a qualitative analysis.患者对难治性或不明原因的慢性咳嗽的体验:定性分析。
Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241236025. doi: 10.1177/17534666241236025.
8
Patterns of Cough Medication Prescribing among Patients with Chronic Cough in Florida: 2012-2021.2012 - 2021年佛罗里达州慢性咳嗽患者止咳药物处方模式
J Clin Med. 2023 Sep 29;12(19):6286. doi: 10.3390/jcm12196286.
9
Characteristics and Management of Patients with Refractory or Unexplained Chronic Cough in Outpatient Hospital Clinics in Spain: A Retrospective Multicenter Study.西班牙门诊医院诊所中难治性或不明原因慢性咳嗽患者的特征和管理:一项回顾性多中心研究。
Lung. 2023 Jun;201(3):275-286. doi: 10.1007/s00408-023-00620-y. Epub 2023 May 9.
10
Canadian Health Care Professionals' Familiarity with Chronic Cough Guidelines and Experiences with Diagnosis and Management: A Cross-Sectional Survey.加拿大医疗保健专业人员对慢性咳嗽指南的熟悉程度以及诊断和管理经验:一项横断面调查。
Lung. 2023 Feb;201(1):47-55. doi: 10.1007/s00408-023-00604-y. Epub 2023 Feb 18.
呼出气一氧化氮在慢性咳嗽中的应用:多步骤方法中的良好工具。
Respir Med Res. 2019 Nov;76:4-9. doi: 10.1016/j.resmer.2019.04.005. Epub 2019 Apr 20.
4
Update on the clinical development of gefapixant, a P2X3 receptor antagonist for the treatment of refractory chronic cough.治疗难治性慢性咳嗽的 P2X3 受体拮抗剂 gefapixant 的临床开发进展。
Pulm Pharmacol Ther. 2019 Jun;56:75-78. doi: 10.1016/j.pupt.2019.03.006. Epub 2019 Mar 14.
5
The heterogeneity of chronic cough: a case for endotypes of cough hypersensitivity.慢性咳嗽的异质性:咳嗽超敏反应表型的案例。
Lancet Respir Med. 2018 Aug;6(8):636-646. doi: 10.1016/S2213-2600(18)30150-4. Epub 2018 Jun 18.
6
Phenotyping patients with chronic cough: Evaluating the ability to predict the response to anti-inflammatory therapy.对慢性咳嗽患者进行表型分析:评估预测抗炎治疗反应的能力。
Ann Allergy Asthma Immunol. 2018 Mar;120(3):285-291. doi: 10.1016/j.anai.2017.12.004.
7
Effects of a novel sodium channel blocker, GSK2339345, in patients with refractory chronic cough
.新型钠通道阻滞剂GSK2339345对难治性慢性咳嗽患者的影响
Int J Clin Pharmacol Ther. 2017 Sep;55(9):712-719. doi: 10.5414/CP202804.
8
XEN-D0501, a Novel Transient Receptor Potential Vanilloid 1 Antagonist, Does Not Reduce Cough in Patients with Refractory Cough.XEN-D0501,一种新型瞬时受体电位香草素 1 拮抗剂,不能减少难治性咳嗽患者的咳嗽。
Am J Respir Crit Care Med. 2017 Nov 15;196(10):1255-1263. doi: 10.1164/rccm.201704-0769OC.
9
Treatment of Neurogenic Cough with Tramadol: A Pilot Study.曲马多治疗神经源性咳嗽:一项初步研究。
Otolaryngol Head Neck Surg. 2017 Jul;157(1):77-79. doi: 10.1177/0194599817703949. Epub 2017 May 2.
10
Chronic cough and cough hypersensitivity syndrome.慢性咳嗽与咳嗽高敏综合征
Lancet Respir Med. 2016 Dec;4(12):934-935. doi: 10.1016/S2213-2600(16)30373-3. Epub 2016 Nov 22.